KaloBios names Martin Shkreli CEO By: MarketMinute.com Stock News November 20, 2015 at 12:35 PM EST KaloBios Pharmaceuticals Inc. (Nasdaq: KBIO) named Martin Shkreli to the position of chief executive officer sending the stock price soaring $7.81 to $18.21.